The Canadian arm of the world’s largest randomized control trial on COVID-19 therapeutics has shown…
pthomsonJanuary 20, 2022
At some B.C. COVID-19 vaccine clinics, including the province’s largest at the Vancouver Convention Centre,…
pthomsonJanuary 18, 2022
This week we profile a recent publication in Development from Matthew Shannon in Dr. Alexander…
pthomsonJanuary 18, 2022
A COVID-19 treatment developed in partnership between Vancouver biotech AbCellera Biologics Inc. (Nasdaq:ABCL) and U.S.…
pthomsonJanuary 17, 2022
Congratulations to the BC Children’s Hospital Research Institute (BCCHR) investigators and their teams who were…
pthomsonJanuary 17, 2022
Many pregnancy disorders, including early-onset preeclampsia (EOPE), are associated with defects in placental trophoblast cell…
pthomsonJanuary 14, 2022
Four Simon Fraser University researchers are among the country’s new and renewed Canada Research Chairs…
pthomsonJanuary 13, 2022
This week, Conversations That Matter features the remarkable Dr. Allen Eaves, the founder, CEO and…
sciencecityOctober 10, 2017
In 2012, 14-year-old Madeline Lauener received a stem cell transplant from her sister as treatment…
sciencecityOctober 10, 2017
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed…
sciencecityOctober 9, 2017
MSFHR is delighted to convene the first MSFHR Research Leaders Forum, a group of internationally recognized…
sciencecityOctober 6, 2017
InMed Pharmaceuticals, Inc., a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug…
sciencecityOctober 6, 2017
TxCell SA a developer of cellular immunotherapies based on regulatory T cells (Tregs) for inflammation, autoimmunity…
sciencecityOctober 5, 2017
This week Conversations That Matter features the remarkable Dr. Allen Eaves, the founder, CEO and…
sciencecityOctober 3, 2017
The neonatal intensive care unit (NICU) at BC Women’s Hospital + Health Centre cares for…
sciencecityOctober 2, 2017
